Skip to content

Advertisement

  • Erratum
  • Open Access

Erratum: Preoperative chemosensitivity testing as Predictor of Treatment benefit in Adjuvant stage III colon cancer (PePiTA): Protocol of a prospective BGDO (Belgian Group for Digestive Oncology) multicentric study

  • 1Email author,
  • 1,
  • 1,
  • 2,
  • 1,
  • 3,
  • 4,
  • 5,
  • 1,
  • 1,
  • 6,
  • 10,
  • 6,
  • 7,
  • 8,
  • 9,
  • 1,
  • 1,
  • 10 and
  • 3
BMC Cancer201515:173

https://doi.org/10.1186/s12885-015-1181-5

  • Received: 3 March 2015
  • Accepted: 5 March 2015
  • Published:

The original article was published in BMC Cancer 2013 13:190

Erratum

After publication of this work [1], we noted that we inadvertently failed to include the complete list of all co-authors. The full list of authors and the corrected Authors Contributions section are reported below. We apologize for any inconvenience this oversight may have caused.

Corrected Authors’ List

Alain Hendlisz1*, Vassilis Golfinopoulos1, Amelie Deleporte1, Marianne Paesmans2, Hazem El Mansy1, Camilo Garcia3, Marc Peeters4, Lieven Annemans5, Caroline Vandeputte1, Marion Maetens1, Marc Van den Eynde6, Raphaël Maréchal10, Ivan Borbath6, Damien Dresse7, Ghislain Houbiers8, Michael Fried9, Ahmad Awada1, Martine Piccart1, Jean-Luc Van Laethem10 and Patrick Flamen3

Corrected Authors' contributions

AH, PM, VG Contribution to protocol writing, Manuscript design, Setting-up the trial, Writing manuscript; HEM, AD, CV, MM, MVDE, RM, Writing manuscript; CG, PF, Contribution to protocol writing, Manuscript design, Setting-up the trial, Writing manuscript, Coordination of PET imaging network; PM, AA, MP, Contribution to protocol writing, Setting-up the trial; JVL, Contribution to protocol writing, Setting-up the trial, Writing manuscript. All authors read and approved the final manuscript.

Notes

Authors’ Affiliations

(1)
Medicine Department, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium
(2)
Data Center, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium
(3)
Nuclear Medicine Department, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium
(4)
Department of Oncology, Antwerp University Hospital, Antwerp, Belgium
(5)
Health Economics, Department of Public Health, Ghent University, Ghent, Belgium
(6)
Gastroenterology Department, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium
(7)
Service de Chirurgie Abdominale et Générale, Centre Hospitalier Régional La Citadelle, Liège, Belgium
(8)
Service d’Oncologie et d’Hématologie, CH Saint Joseph, Liège, Belgium
(9)
Oncology department, Ziekenhuis Netwerk Antwerpen, Antwerpen, Belgium
(10)
Gastroenterology Department, Erasme Hospital, Université Libre de Bruxelles, Brussels, Belgium

Reference

  1. Alain H, Vassilis G, Amelie D, Marianne P, Hazem El M, Camilo G, et al. Preoperative chemosensitivity testing as Predictor of Treatment benefit in Adjuvant stage III colon cancer (PePiTA): Protocol of a prospective BGDO (Belgian Group for Digestive Oncology) multicentric study. BMC Cancer. 2013;13:190.View ArticleGoogle Scholar

Copyright

Advertisement